Multiple interfaces control activity of the Candida glabrata Pdr1 transcription factor mediating azole drug resistance

被引:0
|
作者
W. Scott Moye-Rowley
机构
[1] University of Iowa,Department of Molecular Physiology and Biophysics, Carver College of Medicine
来源
Current Genetics | 2019年 / 65卷
关键词
Candida glabrata; Pdr1; Azole resistance; Transcriptional regulation;
D O I
暂无
中图分类号
学科分类号
摘要
The Cys6Zn2 DNA-binding domain transcription factor Pdr1 is a central regulator of drug resistance in the pathogenic yeast Candida glabrata. In this review, I discuss the multiple control mechanisms modulating the function of this positive transcriptional regulator. Available data suggest that Pdr1 activity is restrained by multiple negative inputs that can be lost by either mutagenesis of the protein or loss of trans-acting factors. Although extensive data are available on the C. glabrata transactivator as well as its cognate proteins in Saccharomyces cerevisiae, the physiological rationale underlying the regulation of these factors remains to be understood.
引用
收藏
页码:103 / 108
页数:5
相关论文
共 49 条
  • [21] The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance
    Nawrocki, A
    Fey, SJ
    Goffeau, A
    Roepstorff, P
    Larsen, PM
    PROTEOMICS, 2001, 1 (08) : 1022 - 1032
  • [22] Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility
    Pais, Pedro
    Galocha, Monica
    California, Raquel
    Viana, Romeu
    Ola, Mihaela
    Okamoto, Michiyo
    Chibana, Hiroji
    Butler, Geraldine
    Teixeira, Miguel C.
    JOURNAL OF FUNGI, 2022, 8 (01)
  • [23] The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance (vol 1, pg 1022, 2001)
    Nawrocki, A
    Fey, SJ
    Goffeau, A
    Roepstorff, P
    Larsen, PM
    PROTEOMICS, 2001, 1 (10) : 1340 - 1341
  • [24] The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways
    Vu, Bao Gia
    Stamnes, Mark A.
    Li, Yu
    Rogers, David
    Moye-Rowley, W. Scott
    PLOS GENETICS, 2021, 17 (09):
  • [25] A yeast cell-based system for screening Candida glabrata multidrug resistance reversal agents and selection of loss-of-function pdr1 mutants
    Goffa, Eduard
    Bialkova, Alexandra
    Batova, Monika
    Dzugasova, Vladimira
    Subik, Julius
    FEMS YEAST RESEARCH, 2011, 11 (02) : 155 - 159
  • [26] Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae
    Talibi, D
    Raymond, M
    JOURNAL OF BACTERIOLOGY, 1999, 181 (01) : 231 - 240
  • [27] The SAGA components GCN5 and ADA2 influence the activity of fluconazole against Candida glabrata independent of the PDR1 transcriptional pathway.
    Whaley, Sarah G.
    Barker, Katherine S.
    Rogers, P. David
    PHARMACOTHERAPY, 2012, 32 (10): : E293 - E293
  • [28] The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans
    Shrivastava, Manjari
    Kouyoumdjian, Gaelle S.
    Kirbizakis, Eftyhios
    Ruiz, Daniel
    Henry, Manon
    Vincent, Antony T.
    Sellam, Adnane
    Whiteway, Malcolm
    MBIO, 2023, 14 (05):
  • [29] Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata
    Miyazaki, H
    Miyazaki, Y
    Geber, A
    Parkinson, T
    Hitchcock, C
    Falconer, DJ
    Ward, DJ
    Marsden, K
    Bennett, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1695 - 1701
  • [30] Membrane-active compounds activate the transcription factors Pdr1 and Pdr3 connecting pleiotropic drug resistance and membrane lipid homeostasis in Saccharomyces cerevisiae
    Schueller, Christoph
    Mamnun, Yasmine M.
    Wolfger, Hubert
    Rockwell, Nathan
    Thorner, Jeremy
    Kuchler, Karl
    MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (12) : 4932 - 4944